Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
UBS AG (NASDAQ:WUCT) has filed a Rule 424(b)(2) prospectus supplement for the launch of Capped Leveraged Buffered S&P 500 Index-Linked Medium-Term Notes maturing in roughly 13-15 months. The notes provide 250 % upside participation on positive S&P 500 performance, but gains are capped by a maximum settlement of $1,100.50–$1,118.00 per $1,000 face amount (equivalent to a cap level of about 104.02 %–104.72 % of the initial index level).
Downside risk is partially mitigated: investors are repaid principal if the index falls ≤10 %, yet losses accelerate to ≈1.1111 % per 1 % decline beyond that buffer, resulting in potential loss of the entire investment. The notes pay no interest or dividends and expose holders to UBS credit risk.
The preliminary estimated initial value is $957.50–$987.50 (95.75–98.75 % of face), versus a 100 % issue price. Gross proceeds will be reduced by a 1.08 % underwriting discount, leaving net proceeds at 98.92 % of face. Secondary-market trading is expected to be limited and may occur at prices below intrinsic value. The filing highlights extensive risk factors, including market volatility, liquidity constraints and conflicts of interest stemming from UBS Securities LLC’s dual role as underwriter and market maker.
UBS AG has filed a 424B2 prospectus supplement for the ETRACS Whitney US Critical Technologies ETN (NYSE:WUCT). The issue is a series of Trigger Callable Contingent Yield Notes maturing 12 Jul 2028 and linked to the worst performer of the Nasdaq-100, Russell 2000 and S&P 500 indices. Investors may receive a 10.15% per-annum contingent coupon on any monthly observation date when all three indices close at or above 70 % of their respective initial levels. UBS can redeem the notes in whole on any observation date after three months, paying par plus the applicable coupon.
If the notes are not called and any index finishes below the 70 % downside threshold at final valuation, repayment is reduced one-for-one with the weakest index’s decline, potentially to zero. The preliminary estimated initial value is $935.20-$965.20 per $1,000 face, reflecting the $2.50 underwriting discount and UBS funding costs. The notes are unsecured obligations of UBS, will not be listed on any exchange, and are subject to both market and issuer credit risk.
- Trade date: 7 Jul 2025 Settlement: 10 Jul 2025 (T+3)
- Maturity: 12 Jul 2028
- Coupon barrier & downside threshold: 70 % of initial level
- Issuer call feature: Monthly, beginning after 3 months
- Estimated initial value: 93.5-96.5 % of par CUSIP: 90308V6K2
Key risks disclosed include full principal loss if thresholds are breached, no guarantee of any coupon, early call risk that caps income, liquidity constraints and UBS’s creditworthiness.